We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
- Authors
Escudier, Bernard; Eisen, Tim; Stadler, Walter M; Szczylik, Cezary; Oudard, Stéphane; Staehler, Michael; Negrier, Sylvie; Chevreau, Christine; Desai, Apurva A; Rolland, Frédéric; Demkow, Tomasz; Hutson, Thomas E; Gore, Martin; Anderson, Sibyl; Hofilena, Gloria; Shan, Minghua; Pena, Carol; Lathia, Chetan; Bukowski, Ronald M
- Abstract
Mature survival data and evaluation of vascular endothelial growth factor (VEGF) as a prognostic biomarker from the Treatment Approaches in Renal Cancer Global Evaluation Trial (TARGET) study in patients with renal cell carcinoma (RCC) are reported.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 20, p3312
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.19.5511